IQVIA Gains as Investors Reassess Strong Backlog, Raised EPS Outlook

IQVIA Holdings (IQV) is up 9.4% today. Here is some analysis on what might have caused this price movement.

Analysis: A clear same-day company announcement was not easy to identify, so the move appears tied to investors revisiting IQVIA’s underlying fundamentals after recent weakness. This could be because the company had already posted solid first-quarter growth, raised its 2026 adjusted EPS outlook, and showed healthy demand signals in its R&D business, which may have encouraged a sharp rebound.

Details:

In its first-quarter 2026 release, IQVIA reported revenue growth of 8.4% year over year, with adjusted diluted EPS of $2.90 and free cash flow up 15%.

The company raised its full-year 2026 adjusted diluted EPS guidance to $12.65 to $12.95 while keeping its revenue and adjusted EBITDA outlook in place.

IQVIA said its R&D Solutions contracted backlog reached $34.2 billion, with about $8.9 billion expected to convert to revenue over the next twelve months, indicating continued visibility.

Recent strategic actions also support the story, including a planned acquisition of drug discovery assets from Charles River and a June debt refinancing transaction intended to refinance existing borrowings.

Sources:

IQVIA Investor Relations, SEC, Nasdaq

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive IQV Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$IQV Hedge Fund Activity

We have seen 517 institutional investors add shares of $IQV stock to their portfolio, and 629 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ARTISAN PARTNERS LIMITED PARTNERSHIP added 1,687,480 shares (+50.1%) to their portfolio in Q1 2026, for an estimated $287,782,839
ORBIS ALLAN GRAY LTD removed 1,682,843 shares (-88.5%) from their portfolio in Q1 2026, for an estimated $286,992,045
FMR LLC removed 1,628,128 shares (-46.8%) from their portfolio in Q1 2026, for an estimated $277,660,949
VICTORY CAPITAL MANAGEMENT INC added 1,614,063 shares (+2628.1%) to their portfolio in Q4 2025, for an estimated $363,825,940
AMERIPRISE FINANCIAL INC added 1,132,167 shares (+230.0%) to their portfolio in Q1 2026, for an estimated $193,079,760
FARALLON CAPITAL MANAGEMENT LLC removed 938,551 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $211,558,780
AQR CAPITAL MANAGEMENT LLC removed 898,370 shares (-42.0%) from their portfolio in Q1 2026, for an estimated $153,208,019

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$IQV Congressional Stock Trading

Members of Congress have traded $IQV stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $IQV stock by members of Congress over the last 6 months:

REPRESENTATIVE KEVIN HERN sold up to $100,000 on 03/16.
SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 12/29.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$IQV Analyst Ratings

Wall Street analysts have issued reports on $IQV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Truist Securities issued a "Buy" rating on 01/08/2026
UBS issued a "Buy" rating on 01/08/2026

To track analyst ratings and price targets for $IQV, check out Quiver Quantitative's $IQV forecast page.

$IQV Price Targets

Multiple analysts have issued price targets for $IQV recently. We have seen 11 analysts offer price targets for $IQV in the last 6 months, with a median target of $220.0.

Here are some recent targets:

Kallum Titchmarsh from Morgan Stanley set a target price of $200.0 on 06/17/2026
Elizabeth Anderson from Evercore ISI Group set a target price of $185.0 on 04/08/2026
Charles Rhyee from TD Cowen set a target price of $213.0 on 03/09/2026
Luke Sergott from Barclays set a target price of $210.0 on 03/06/2026
Ryan Halsted from RBC Capital set a target price of $221.0 on 03/03/2026
Jailendra Singh from Truist Securities set a target price of $245.0 on 02/19/2026
Shlomo Rosenbaum from Stifel set a target price of $220.0 on 02/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.